Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis  J.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012  M. Tvede,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France  D.
J.-C. Lagier  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre  J.M. Cisneros, O. Neth, M.V.
European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection  S.B.
Herpes zoster in non-hospitalized children
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics  Y.H. van Beurden, S. Nezami,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors  S.B. Debast, N. Vaessen, A. Choudry,
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
E. Bouza  Clinical Microbiology and Infection 
P. Davey, C. Pagliari, A. Hayes  Clinical Microbiology and Infection 
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan  P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Impact of antibiotic restrictions: the pharmaceutical perspective
Vector control: a cornerstone in the malaria elimination campaign
E. Bouza, P. Muñoz, R. Alonso  Clinical Microbiology and Infection 
Training for the infectious diseases speciality in Norway
B. Huttner, S. Harbarth, D. Nathwani 
Community-acquired pneumonia: the evolving challenge
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Elements of design: the knowledge on which we build
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Mathematical modeling of Clostridium difficile infection
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
The economic burden of Clostridium difficile
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Abstracts cont. Clinical Microbiology and Infection
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.
Reducing antibiotic use in influenza: challenges and rewards
Clinical infection services—the Leiden experience
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Clinical Microbiology and Infection
Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre  J.M. Cisneros, O. Neth, M.V.
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
C.P. Kelly  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
A. Ramette, J.M. Tiedje, A. Boetius 
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Typing of Clostridium difficile
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis  J. Price, E. Cheek, S. Lippett, M. Cubbon, D.N. Gerding, S.P. Sambol, D.M. Citron, M. Llewelyn  Clinical Microbiology and Infection  Volume 16, Issue 8, Pages 1297-1302 (August 2010) DOI: 10.1111/j.1469-0691.2009.03077.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Monthly antibiotic use (defined daily doses), Clostridium difficile infection (CDI) rate for nosocomial cases, total number of CDI cases and bed days between January 2007 and March 2009. Clinical Microbiology and Infection 2010 16, 1297-1302DOI: (10.1111/j.1469-0691.2009.03077.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2010 16, 1297-1302DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, 1297-1302DOI: (10.1111/j.1469-0691.2009.03077.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

Clinical Microbiology and Infection 2010 16, 1297-1302DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, 1297-1302DOI: (10.1111/j.1469-0691.2009.03077.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions